secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERACYTE, INC. (VCYT)
CIK:        0001384101
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001384101-25-000106
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Veracyte Q2 revenue $130.2M (+14% YoY); raises testing revenue guidance
-----------------------------------------------------------------------

- Total revenue of $130.2M (+14% YoY); testing revenue of $122.3M (+14%).
- Decipher revenue $76.3M (+24%), volume ~25,500 (+28%); Afirma revenue $43.4M (+5%).
- GAAP net loss $1.0M includes $20.5M impairment; adj. EBITDA $35.8M (27.5% of revenue).
- Cash from operations $33.6M; cash & investments $320.7M at quarter end.
- Raises FY2025 testing revenue guidance to $477-483M (14-15% growth); FY total revenue $496-504M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1384101/000138410125000106/0001384101-25-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1384101/000138410125000106/vcyt-20250806.htm
  HTML page:      https://secwatch.observer/filing/0001384101-25-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer